AN ANALYSIS OF MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER WHO DEFERRED DEFINITIVE THERAPY-Reference-Cited by-同舟云学术

AN ANALYSIS OF MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER WHO DEFERRED DEFINITIVE THERAPY

Published:2004-04 Issue:4 Volume:171 Page:1520-1524
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

PATEL MANISH I.¹,DeCONCINI DINO T.¹,LOPEZ-CORONA ERNESTO¹,OHORI MAKATO¹,WHEELER THOMAS¹,SCARDINO PETER T.¹

Affiliation:

1. From the Department of Urology, Memorial Sloan-Kettering Cancer Center (MIP, EL-C, MO, PTS), New York, New York, Department of Surgery, University of Sydney (MIP), Sydney, Australia, and Departments of Urology (DTD) and Pathology (TW), Baylor College of Medicine, Houston, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Results of conservative management of clinically localized prostate cancer;Chodak;N Engl J Med,1994

2. Long-term survival among men with conservatively treated localized prostate cancer;Albertsen;JAMA,1995

3. High 10-year survival rate in patients with early, untreated prostatic cancer;Johansson;JAMA,1992

4. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening;Humphrey;J Urol,1996

5. Watchful waiting or watchful progression? Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma;McLaren;Cancer,1998

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active Surveillance for Prostate Cancer: Past, Current, and Future Trends;Journal of Personalized Medicine;2023-04-03

2. Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low‐ and very‐low risk prostate cancer;Cancer Medicine;2022-11-20

3. Evolution of Focal Therapy in Prostate Cancer;Urologic Clinics of North America;2022-02

4. Cause-specific mortality of low and selective intermediate-risk prostate cancer patients with active surveillance or watchful waiting;Translational Andrology and Urology;2021-01

5. Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma;The Journal of Clinical Endocrinology & Metabolism;2020-11-28